Influence of maternal hyperglycemia on IL-10 and TNF-α production: The relationship with perinatal outcomes

Journal of Clinical Immunology

Volumn 32, Issue 3, 2012, Pages 604-610

  Moreli, Jusciele Brogin ^a   Morceli, Glilciane ^a   De Luca, Ana Karina C ^a   Magalhães, Claudia G ^a   Costa, Roberto A A ^a   Damasceno, Débora Cristina ^a   Rudge, Marilza Vieira Cunha ^a   Calderon, Iracema Mattos Paranhos ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cytokines; diabetes; mild gestational hyperglycemia; perinatal outcomes; placenta

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BODY MASS; CESAREAN SECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; FEMALE; FETUS MONITORING; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERINSULINEMIA; INFANT; INSULIN BLOOD LEVEL; INTRAUTERINE NUTRITION; INTRAUTERINE OXYGENATION; MACROSOMIA; MATERNAL BLOOD; MATERNAL HYPERGLYCEMIA; NEWBORN; OUTCOME ASSESSMENT; PERINATAL DEVELOPMENT; PERINATAL PERIOD; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; INSULIN; INTERLEUKIN-10; OXYGEN; PLACENTA; PREGNANCY; PREGNANCY IN DIABETICS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84861482018     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9634-3     Document Type: Article

References (27)

1. American Diabetes Association (ADA). Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1:S62-9.
2. Rudge MV, Calderon IM, Ramos MD, Abbade JF, Rugolo LM. Perinatal outcome of pregnancies complicated by diabetes and by maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest. 2000;50:108-12.
3. Eriksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers - animal and human studies. Rev Endocr Metab Disord. 2003;4:79-93. (Pubitemid 36182153)
4. Rudge MVC, Calderon IMP, Ramos MD, Brasil MAM, Rugolo LMSS, Bossolan G, et al. Hiperglicemiamaterna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27:691-7.
5. Yang J, Cummings EA, O'Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006;108:644-50. (Pubitemid 44337107)
6. Calderon IMP, Kerche LTRL, Damasceno DC, Rudge MVC. Diabetes and pregnancy: an update of the problem. ARBS. 2007;9:1-11.
7. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:1-6.
8. Hod M, Haroush AB, Yogev Y. Pathogenesis of gestational diabetes mellitus. In: Hod M, Jovanovic L, Leiva GCRA, Langer O, editors. Textbook of diabetes and pregnancy. London: Informa Healthcare; 2003. p. 39-49.
9. Vela-Huerta MM, San Vicente-Santoscoy EU, Guizar-Mendoza JM, Amador-Licona N, Aldana-Valenzuela C, Hernnandez J. Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers. J Pediatr Endocrinol Metab. 2008;21:17-22. (Pubitemid 351350838)
10. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676-82.
11. Metzger E, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. The HAPO Study Cooperative Research Group. N Engl J Med. 2008;358:1991-2002. (Pubitemid 351656454)
12. Rudge MVC, Peraçoli JC, Berezowski AT, Calderon IMP, Brasil MAM. The oral glucose tolerance test is a poor predictor of hyperglycemia during pregnancy. Braz J Med Biol Res. 1990;23:1079-89.
13. Bjork O, Persson B. Villous structure in different parts of the cotyledon in placentas of insulin-dependent diabetic women. A morphometric study. Acta Obstet Gynecol Scand. 1984;63:37-43. (Pubitemid 14173138)
14. Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003;24:343-7. (Pubitemid 37184752)
15. Calderon IM, Damasceno DC, Amorin RL, Costa RA, Brasil MA, Rudge MV. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract. 2007;78:65-71. (Pubitemid 47348144)
16. Sgarbosa F, Barbisan LF, Brasil MAM, Costa E, Calderon IMP, Gonçalves CR, et al. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract. 2006;73:143-9. (Pubitemid 43928159)
17. Pietro L, Daher S, RudgeMV, Calderon IM, Damasceno DC, Sinzato YK, et al. Vascular endothelial growth factor (VEGF) and VEGFreceptor expression in placenta of hyperglycemic pregnant women. Placenta. 2010;3:7707-80.
18. Carvalho Silva SAL. Dopplervelocimetria da artéria umbilical como marcador de alterações imunológicas placentárias e de risco de morte perinatal em gestações complicadas por diabete ou hiperglicemia leve [tese]. Faculdade de medicina (Botucatu): Universidade Estadual Paulista; 2010.
19. Thaxton JE, Sharma S. Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol. 2010;63:482-91.
20. Coughlan MT, Oliva K, Georgiou HM, Permezel JM, Rice GE. Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med. 2001;18:921-7. (Pubitemid 34062962)
21. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. TNFalpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207-13. (Pubitemid 34729026)
22. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111-47. (Pubitemid 19254750)
23. Negrato CA, Jovanovic L, Tambascia MA, Calderon Ide M, Geloneze B, Dias A, et al. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24:324-30. (Pubitemid 351802798)
24. Rudge MVC, Calderon IMP, Ramos MD, Maestá I, Souza LMS, Peraçoli JC. Perspectiva perinatal decorrentes do rígido controle pré-natal em gestações complicadas pelodiabete. Rev Bras Ginecol Obstet. 1995;17:26-32.
25. Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11:212-7. (Pubitemid 30603166)
26. Montazeri S, Nalliah S, Radhakrishnan AK. Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas. 2010;147:94-102.
27. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30:S121-6.